Related Experiment Videos
Reye-like syndrome associated with valproic acid.
Brain & Development
|January 1, 1983
Summary
Valproic acid (VPA) treatment can cause Reye-like syndrome, leading to hyperammonemia and severe liver damage. Mitochondrial abnormalities were observed in liver biopsies, indicating VPA toxicity.
Area of Science:
- Biochemistry
- Toxicology
- Pathology
Background:
- Valproic acid (VPA) is a widely used antiepileptic and mood-stabilizing drug.
- Reye-like syndrome is a rare but serious condition characterized by acute non-inflammatory encephalopathy and fatty degeneration of the liver.
Observation:
- A patient undergoing VPA treatment developed a Reye-like syndrome.
- Clinical presentation included hyperammonemia and severe liver damage.
- Liver biopsy revealed diffuse small droplets, mitochondrial deformation, cristae loss, and matrix deposits.
Findings:
- Gas chromatography/mass spectrometry detected VPA metabolites, lactate, and other substances in urine.
- Electron microscopy confirmed mitochondrial pathology in liver tissue.
- These findings suggest a direct link between VPA and the observed Reye-like syndrome.
Implications:
- This case highlights a potential severe adverse effect of VPA therapy.
- It underscores the importance of monitoring liver function and ammonia levels in patients on VPA.
- Understanding VPA-induced mitochondrial dysfunction is crucial for managing and preventing such complications.